FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288702941> ?p ?o ?g. }

• W4288702941 endingPage "1147" @default.
• W4288702941 startingPage "1139" @default.
• W4288702941 abstract "Abstract The treatment of persistent erythema and rosacea flushing is extremely challenging, especially for patients with anxiety. The aim of this study was to verify the efficacy of carvedilol in rosacea patients with persistent erythema and flushing. A total of 156 patients were randomized to use oral carvedilol 5 mg bid (twice per day) ( n = 105) or topical brimonidine ( n = 51) for a 10‐week period with 6 weeks of follow‐up. Both the efficacy of carvedilol and the status of anxiety/depression were analyzed by patient self‐assessment (PSA), clinician erythema assessment (CEA), generalized anxiety disorder (GAD‐7), and patient health questionnaire‐9 (PHQ‐9). Our study found that carvedilol exerted a dramatic reduction in CEA/PSA scores and sting/burning sensation scores in comparison to topical brimonidine. Additionally, carvedilol treatment dramatically improved telangiectasia, erythema, and pigmentation with no obvious side effects. Patients with carvedilol treatment showed an improvement of depression/anxiety, as reflected by lower GAD‐7 and PHQ‐9 scores than patients with topical brimonidine. Notably, we found carvedilol treatment had better outcomes among patients under 30 years of age with rosacea younger than 30 years old. Conclusively, our findings reveal that carvedilol could quickly and effectively improve facial erythema, which might stem from the improved the status of anxiety/depression." @default.
• W4288702941 created "2022-07-30" @default.
• W4288702941 creator A5002982520 @default.
• W4288702941 creator A5009658619 @default.
• W4288702941 creator A5018165993 @default.
• W4288702941 creator A5021596200 @default.
• W4288702941 creator A5033684035 @default.
• W4288702941 creator A5045888002 @default.
• W4288702941 creator A5050733798 @default.
• W4288702941 creator A5052883326 @default.
• W4288702941 creator A5065563933 @default.
• W4288702941 creator A5067769933 @default.
• W4288702941 creator A5091624552 @default.
• W4288702941 date "2022-07-29" @default.
• W4288702941 modified "2023-09-26" @default.
• W4288702941 title "Carvedilol ameliorates persistent erythema of erythematotelangiectatic rosacea by regulating the status of anxiety/depression" @default.
• W4288702941 cites W1972997429 @default.
• W4288702941 cites W1976118708 @default.
• W4288702941 cites W2009117462 @default.
• W4288702941 cites W2023560341 @default.
• W4288702941 cites W2047454818 @default.
• W4288702941 cites W2049663710 @default.
• W4288702941 cites W2052419518 @default.
• W4288702941 cites W2132211535 @default.
• W4288702941 cites W2145159782 @default.
• W4288702941 cites W2147607858 @default.
• W4288702941 cites W2293115986 @default.
• W4288702941 cites W2474892006 @default.
• W4288702941 cites W2733972807 @default.
• W4288702941 cites W2739744160 @default.
• W4288702941 cites W2888753367 @default.
• W4288702941 cites W2967093367 @default.
• W4288702941 cites W2969704529 @default.
• W4288702941 cites W3012843977 @default.
• W4288702941 cites W3021577927 @default.
• W4288702941 cites W3178733483 @default.
• W4288702941 cites W3211494786 @default.
• W4288702941 cites W4211092530 @default.
• W4288702941 doi "https://doi.org/10.1111/1346-8138.16525" @default.
• W4288702941 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35904063" @default.
• W4288702941 hasPublicationYear "2022" @default.
• W4288702941 type Work @default.
• W4288702941 citedByCount "1" @default.
• W4288702941 countsByYear W42887029412023 @default.
• W4288702941 crossrefType "journal-article" @default.
• W4288702941 hasAuthorship W4288702941A5002982520 @default.
• W4288702941 hasAuthorship W4288702941A5009658619 @default.
• W4288702941 hasAuthorship W4288702941A5018165993 @default.
• W4288702941 hasAuthorship W4288702941A5021596200 @default.
• W4288702941 hasAuthorship W4288702941A5033684035 @default.
• W4288702941 hasAuthorship W4288702941A5045888002 @default.
• W4288702941 hasAuthorship W4288702941A5050733798 @default.
• W4288702941 hasAuthorship W4288702941A5052883326 @default.
• W4288702941 hasAuthorship W4288702941A5065563933 @default.
• W4288702941 hasAuthorship W4288702941A5067769933 @default.
• W4288702941 hasAuthorship W4288702941A5091624552 @default.
• W4288702941 hasConcept C118487528 @default.
• W4288702941 hasConcept C118552586 @default.
• W4288702941 hasConcept C126322002 @default.
• W4288702941 hasConcept C139719470 @default.
• W4288702941 hasConcept C142724271 @default.
• W4288702941 hasConcept C16005928 @default.
• W4288702941 hasConcept C162324750 @default.
• W4288702941 hasConcept C175259745 @default.
• W4288702941 hasConcept C204787440 @default.
• W4288702941 hasConcept C2776867660 @default.
• W4288702941 hasConcept C2777673923 @default.
• W4288702941 hasConcept C2778081122 @default.
• W4288702941 hasConcept C2778190193 @default.
• W4288702941 hasConcept C2778198053 @default.
• W4288702941 hasConcept C2778527774 @default.
• W4288702941 hasConcept C2779121184 @default.
• W4288702941 hasConcept C2780591200 @default.
• W4288702941 hasConcept C558461103 @default.
• W4288702941 hasConcept C71924100 @default.
• W4288702941 hasConceptScore W4288702941C118487528 @default.
• W4288702941 hasConceptScore W4288702941C118552586 @default.
• W4288702941 hasConceptScore W4288702941C126322002 @default.
• W4288702941 hasConceptScore W4288702941C139719470 @default.
• W4288702941 hasConceptScore W4288702941C142724271 @default.
• W4288702941 hasConceptScore W4288702941C16005928 @default.
• W4288702941 hasConceptScore W4288702941C162324750 @default.
• W4288702941 hasConceptScore W4288702941C175259745 @default.
• W4288702941 hasConceptScore W4288702941C204787440 @default.
• W4288702941 hasConceptScore W4288702941C2776867660 @default.
• W4288702941 hasConceptScore W4288702941C2777673923 @default.
• W4288702941 hasConceptScore W4288702941C2778081122 @default.
• W4288702941 hasConceptScore W4288702941C2778190193 @default.
• W4288702941 hasConceptScore W4288702941C2778198053 @default.
• W4288702941 hasConceptScore W4288702941C2778527774 @default.
• W4288702941 hasConceptScore W4288702941C2779121184 @default.
• W4288702941 hasConceptScore W4288702941C2780591200 @default.
• W4288702941 hasConceptScore W4288702941C558461103 @default.
• W4288702941 hasConceptScore W4288702941C71924100 @default.
• W4288702941 hasFunder F4320321001 @default.
• W4288702941 hasIssue "11" @default.
• W4288702941 hasLocation W42887029411 @default.
• W4288702941 hasLocation W42887029412 @default.

• next